Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 7.1T | 7.1T | 7.2T | 6.7T |
| Cost of revenue | 4.9T | 4.8T | 4.9T | 4.6T |
| Gross profit | 2.2T | 2.2T | 2.3T | 2.1T |
| Operating expense | ||||
| Research & development | 701.3B | 640.5B | 635.4B | 578.0B |
| Selling general and admin | 843.3B | 740.2B | 870.3B | 750.4B |
| Other operating expenses | — | — | — | — |
| Operating income | 686.1B | 860.2B | 806.1B | 767.3B |
| Non operating interest income | ||||
| Income | 103.1B | 113.2B | 106.5B | 103.1B |
| Expense | 13.5B | 13.5B | 15.2B | 15.2B |
| Other income expense | -699.7B | -402.2B | -57.5B | -187.6B |
| Pretax income | 81.1B | 554.3B | 843.3B | 672.6B |
| Tax provision | 226.5B | 174.1B | 223.1B | 165.6B |
| Net income | -145.3B | 380.2B | 620.2B | 507.0B |
| Basic EPS | -0.4 | 1.1 | 1.8 | 1.5 |
| Diluted EPS | -0.4 | 1.1 | 1.8 | 1.5 |
| Basic average shares | 347.2B | 345.6B | 342.9B | 340.7B |
| Diluted average shares | 347.2B | 355.3B | 353.2B | 350.5B |
| EBITDA | 838.2B | 1.0T | 966.7B | 926.1B |
| Net income from continuing op. | -145.3B | 380.2B | 620.2B | 507.0B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |